SOUTHERN MAINE HEALTH CARE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $643K
- Transactions
- 99
- Companies
- 22
- Average per transaction
- $6,498
Who reported the payments
| Eli Lilly | $217,562 |
| Amgen | $125,361 |
| Janssen Research & Development, LLC | $61,582 |
| Genentech, Inc. | $60,072 |
| Novartis | $55,688 |
| SK Life Science, Inc. | $18,631 |
| Ardelyx, Inc. | $15,928 |
| Medical Device Business Services, Inc. | $14,355 |
| Johnson & Johnson | $13,853 |
| Gilead | $12,161 |
| Treace Medical Concepts, Inc. | $10,236 |
| Shockwave Medical, Inc | $9,974 |
| Olympus America Inc. | $8,699 |
| Eisai Inc. | $6,719 |
| GE HealthCare | $6,616 |
| Artivion, Inc. | $2,116 |
| AbbVie | $1,421 |
| KARL Storz Endoscopy-america | $870 |
| Microline Surgical Inc | $833 |
| Bio-rad Laboratories, Inc. | $508 |
| Merck | $96 |
| Medline Industries LP | $42 |